Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Sell
34
SAGE Quote, Financials, Valuation and Earnings
Last price:
$9.15
Seasonality move
:
-9.7%
Day range:
$9.11 - $9.19
52-week range:
$4.62 - $13.47
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
11.79x
P/B ratio:
1.40x
Volume:
1.6M
Avg. volume:
2.5M
1-year change:
-24.92%
Market cap:
$571.7M
Revenue:
$41.2M
EPS (TTM):
-$5.80
Earnings Data
Next earnings date for SAGE
Jul 31
2025
Most recent earnings per share
-$1.01
Beat by $0.00
(Apr 29/2025)
Consensus Estimate
-$1.01
(Apr 29/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
SAGE Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 09/30/2025 | Q3 | $24.4M | -- | -- | -$0.86 | -- |
| 07/31/2025 | Q2 | $16.7M | -- | -- | -$0.94 | -- |
| 04/29/2025 | Q1 | $14M | $14.1M | -$1.01 | -$1.01 | $0.00 |
| 02/11/2025 | Q4 | $14.4M | $12.8M | -$1.56 | -$1.36 | -$0.20 |
| 10/29/2024 | Q3 | $10.9M | $11.9M | -$1.53 | -$1.55 | $0.02 |
| 07/31/2024 | Q2 | $8.9M | $8.7M | -$1.70 | -$1.64 | -$0.06 |
| 04/25/2024 | Q1 | $5.2M | $7.9M | -$1.80 | -$1.64 | -$0.16 |
| 02/14/2024 | Q4 | $61M | $78M | -$0.54 | -$1.29 | $0.75 |
| 11/07/2023 | Q3 | -- | -- | -$3.37 | -$2.69 | -$0.68 |
| 08/07/2023 | Q2 | -- | -- | -$2.68 | -$2.54 | -$0.14 |
| 05/02/2023 | Q1 | -- | -- | -$2.46 | -$2.46 | $0.00 |
| 02/16/2023 | Q4 | -- | -- | -$2.47 | -$2.36 | -$0.11 |
| 11/08/2022 | Q3 | -- | -- | -$2.31 | -$2.19 | -$0.12 |
| 08/02/2022 | Q2 | -- | -- | -$2.13 | -$2.15 | $0.02 |
| 05/03/2022 | Q1 | -- | -- | -$2.07 | -$2.00 | -$0.07 |
| 02/24/2022 | Q4 | -- | -- | -$2.12 | -$2.16 | $0.04 |
| 11/02/2021 | Q3 | -- | -- | -$2.21 | -$1.86 | -$0.35 |
| 08/03/2021 | Q2 | -- | -- | -$1.83 | -$1.69 | -$0.14 |
| 05/04/2021 | Q1 | -- | -- | -$1.64 | -$1.63 | -$0.01 |
| 02/24/2021 | Q4 | -- | -- | $18.19 | -$2.12 | $20.31 |
| 11/05/2020 | Q3 | -- | -- | -$2.03 | -$2.47 | $0.44 |
| 08/10/2020 | Q2 | -- | -- | -$2.63 | -$2.59 | -$0.04 |
| 05/07/2020 | Q1 | -- | -- | -$2.44 | -$3.17 | $0.73 |
| 02/27/2020 | Q4 | -- | -- | -$3.25 | -$3.63 | $0.38 |
| 11/12/2019 | Q3 | -- | -- | -$3.48 | -$3.38 | -$0.10 |
| 08/06/2019 | Q2 | -- | -- | -$3.28 | -$3.35 | $0.07 |
| 05/02/2019 | Q1 | -- | -- | -$3.37 | -$3.19 | -$0.18 |
| 02/19/2019 | Q4 | -- | -- | -$3.38 | -$2.92 | -$0.46 |
| 11/06/2018 | Q3 | -- | -- | -$2.63 | -$2.40 | -$0.23 |
| 08/07/2018 | Q2 | -- | -- | -$0.36 | -$1.82 | $1.46 |
| 05/03/2018 | Q1 | -- | -- | -$1.68 | -$1.81 | $0.13 |
| 02/22/2018 | Q4 | -- | -- | -$1.75 | -$2.01 | $0.26 |
| 11/02/2017 | Q3 | -- | -- | -$1.97 | -$1.93 | -$0.04 |
| 08/03/2017 | Q2 | -- | -- | -$1.88 | -$1.63 | -$0.25 |
| 05/04/2017 | Q1 | -- | -- | -$1.52 | -$1.55 | $0.03 |
| 02/23/2017 | Q4 | -- | -- | -- | -- | -- |
| 11/03/2016 | Q3 | -- | -- | -- | -- | -- |
| 08/09/2016 | Q2 | -- | -- | -- | -- | -- |
| 05/05/2016 | Q1 | -- | -- | -- | -- | -- |
| 02/24/2016 | Q4 | -- | -- | -- | -- | -- |
| 11/05/2015 | Q3 | -- | -- | -- | -- | -- |
Sage Therapeutics Earnings Questions
-
How Much did Sage Therapeutics Generate in Revenue Last Quarter?
Sage Therapeutics reported $14.1M worth of top line sales in its most recent quarter.
-
Did Sage Therapeutics Beat Earnings Last Quarter?
Sage Therapeutics announced earnings per share of -$1.01 which represents a beat of analyst forecast a -$1.01 per share.
-
Is Sage Therapeutics Profitable?
Sage Therapeutics reported $13.4M that represents $0.22 per share over the last quarter.
-
What is the Analyst Consensus for Sage Therapeutics EPS Next Year?
Sage Therapeutics's earnings are forecast to decrease from -$6.59 per share to -$6.38 per share next year representing a decrease of -45.85%.
-
When is Sage Therapeutics's Earnings Date?
Sage Therapeutics's next earnings date is July 31, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
62
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
89
EXOD alert for Jul 17
Exodus Movement [EXOD] is down 4.14% over the past day.
Buy
60
U alert for Jul 17
Unity Software [U] is up 7.51% over the past day.
